| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $629.5M | — | +0.8% |
| Cost of Revenue | $128.1M | — | +9.8% |
| Gross Profit | $501.4M | — | -1.3% |
| R&D Expense | $184.2M | — | +3.3% |
| SG&A Expense | $57.5M | — | +6.9% |
| Operating Income | $172.8M | — | -6.0% |
| Pre-tax Income | $141.4M | — | -16.6% |
| Income Tax | $26.9M | — | +40.1% |
| Net Income | $114.5M | — | -23.8% |
| EPS (Basic) | $0.49 | — | -5.8% |
| EPS (Diluted) | $0.48 | — | -5.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.21B | +35.5% | +28.1% |
| Accounts Receivable | $74.7M | -5.6% | +4.3% |
| Current Assets | $1.45B | +21.7% | +8.5% |
| Total Assets | $3.03B | +6.5% | +2.5% |
| Current Liabilities | $1.18B | -37.9% | -36.0% |
| Total Liabilities | $5.04B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $204.5M | — | +33.0% |
| Capital Expenditures | $1.2M | — | +1100.0% |
| Investing Cash Flow | $66.9M | — | +86.9% |
| Financing Cash Flow | $46.2M | — | +108.0% |
| Free Cash Flow | $203.3M | — | +32.3% |
| +25.0% |
| Stockholders' Equity | -$2.01B | -11.9% | -87.0% |